Total Payments
$10,610
2024 Payments
$1,411
Companies
48
Transactions
680
Medicare Patients
8,238
Medicare Billing
$503,331
Payment Breakdown by Category
Food & Beverage$10,566 (99.6%)
Education$43.23 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,566 | 675 | 99.6% |
| Education | $43.23 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,432 | 90 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,116 | 82 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,083 | 78 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $908.51 | 65 | $0 (2024) |
| PFIZER INC. | $698.11 | 56 | $0 (2024) |
| Amgen Inc. | $683.49 | 46 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $581.91 | 31 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $488.42 | 36 | $0 (2024) |
| iRhythm Technologies, Inc. | $327.38 | 23 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $322.98 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,411 | 72 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($240.86) |
| 2023 | $1,115 | 60 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($184.73) |
| 2022 | $1,190 | 69 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($173.67) |
| 2021 | $1,148 | 76 | Janssen Pharmaceuticals, Inc ($191.13) |
| 2020 | $1,348 | 89 | AstraZeneca Pharmaceuticals LP ($203.87) |
| 2019 | $1,412 | 95 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($223.75) |
| 2018 | $1,596 | 111 | Janssen Pharmaceuticals, Inc ($266.39) |
| 2017 | $1,390 | 108 | Novartis Pharmaceuticals Corporation ($198.53) |
All Payment Transactions
680 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.51 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/17/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/10/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/02/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.45 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/04/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $21.76 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/16/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $32.65 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.52 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,623 | 2,004 | $471,277 | $100,824 |
| 2022 | 20 | 1,883 | 2,303 | $547,211 | $116,193 |
| 2021 | 23 | 2,239 | 2,705 | $652,596 | $143,478 |
| 2020 | 22 | 2,493 | 2,943 | $656,687 | $142,835 |
Total Patients
8,238
Total Services
9,955
Medicare Billing
$503,331
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 356 | 449 | $131,557 | $36,562 | 27.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 190 | $35,530 | $11,649 | 32.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 80 | 80 | $64,240 | $11,029 | 17.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 148 | 149 | $40,677 | $7,179 | 17.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 61 | 66 | $20,517 | $6,585 | 32.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 97 | 97 | $32,786 | $5,281 | 16.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 425 | 547 | $47,042 | $5,260 | 11.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 14 | 14 | $14,560 | $3,089 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 47 | $9,682 | $2,938 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $10,233 | $2,781 | 27.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,510 | $1,479 | 32.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 16 | 16 | $16,640 | $1,318 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 15 | $4,395 | $1,056 | 24.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 95 | 96 | $17,184 | $986.44 | 5.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 22 | $3,014 | $844.80 | 28.0% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 14 | 14 | $4,676 | $821.70 | 17.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 66 | 95 | $3,800 | $594.08 | 15.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 13 | 13 | $5,837 | $587.63 | 10.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 14 | 17 | $1,496 | $315.70 | 21.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 15 | 15 | $1,305 | $274.26 | 21.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 12 | 12 | $1,224 | $165.12 | 13.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 12 | 12 | $372.00 | $28.80 | 7.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 382 | 485 | $142,105 | $40,735 | 28.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 93 | 94 | $75,482 | $12,876 | 17.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 82 | 201 | $34,170 | $10,916 | 31.9% |
About Dr. Peter Vassallo, M.D
Dr. Peter Vassallo, M.D is a Cardiovascular Disease healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760429773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Vassallo, M.D has received a total of $10,610 in payments from pharmaceutical and medical device companies, with $1,411 received in 2024. These payments were reported across 680 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($10,566).
As a Medicare-enrolled provider, Vassallo has provided services to 8,238 Medicare beneficiaries, totaling 9,955 services with total Medicare billing of $503,331. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Pinehurst, NC
- Active Since 05/31/2006
- Last Updated 06/06/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1760429773
Products in Payments
- LifeVest (Device) $1,432
- XARELTO (Drug) $1,083
- ENTRESTO (Drug) $1,056
- ELIQUIS (Drug) $992.71
- BRILINTA (Drug) $655.27
- Corlanor (Drug) $391.35
- VERQUVO (Drug) $304.55
- JARDIANCE (Drug) $299.24
- Repatha (Biological) $292.14
- PRADAXA (Drug) $282.67
- MULTAQ (Drug) $270.04
- FARXIGA (Drug) $256.41
- NORTHERA (Drug) $221.45
- NEXLETOL (Drug) $180.97
- FUROSCIX (Drug) $163.28
- Kerendia (Drug) $143.03
- Impella (Device) $139.78
- WATCHMAN Access System (Device) $131.16
- ZIO Patch (Device) $129.43
- ZIO XT Patch (Device) $120.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Pinehurst
Patrick Simpson, Md, MD
Cardiovascular Disease — Payments: $816,276
Cardiovascular Disease $816,276
Herbert Strunk, Do, DO
Cardiovascular Disease — Payments: $15,303
Cardiovascular Disease $15,303
Keith Davis, Md, MD
Cardiovascular Disease — Payments: $11,216
Cardiovascular Disease $11,216
Ker Boyce, Md, MD
Cardiovascular Disease — Payments: $10,577
Cardiovascular Disease $10,577
David Cowherd, Md, MD
Cardiovascular Disease — Payments: $7,578
Cardiovascular Disease $7,578
Joseph Parrish, Md, MD
Cardiovascular Disease — Payments: $3,421
Cardiovascular Disease $3,421